Table Filtering
Submissions
GlyTouCan
Glycan Structure Repository
GlyComb
Glycoconjugate Repository
GlycoPOST
Glycomics MS raw data Repository
UniCarb-DR
Glycomics MS Repository for glycan annotations from GlycoWorkbench
All Resources
Genes / Proteins / Lipids Glycans / Glycoconjugates Glycomes Pathways / Interactions / Diseases / Organisms
GlycoNAVI Proteins
GlycoNAVI-Proteins is dataset of glycan and protein information. This is the content of GlycoNAVI.
| Source | Last Updated |
|---|---|
| GlycoNAVI Proteins | November 21, 2024 |
| PDB ID | UniProt ID ▲ | Title | Descriptor |
|---|---|---|---|
| 7LI9 | 7LI9 | 5-HT bound serotonin transporter reconstituted in lipid nanodisc in KCl | |
| 7LIA | 7LIA | 5-HT bound serotonin transporter reconstituted in lipid nanodisc in presence of NaCl in outward facing conformation | |
| 7LKC | 7LKC | Crystal Structure of Keratinimicin A | |
| 7LKF | 7LKF | WT Chicken Scap L1-L7 / Fab 4G10 complex focused refinement | |
| 7LKH | 7LKH | Chicken Scap D435V L1-L7 domain / Fab complex focused map | |
| 7LL1 | 7LL1 | Cryo-EM structure of BG505 DS-SOSIP in complex with glycan276-dependent broadly neutralizing antibody VRC40.01 Fab | |
| 7LL2 | 7LL2 | Cryo-EM structure of BG505 DS-SOSIP in complex with Glycan276-Dependent Broadly Neutralizing Antibody VRC33.01 Fab | |
| 7LLK | 7LLK | Cryo-EM structure of Q23.17_DS-SOSIP in complex with Glycan276-Dependent Broadly Neutralizing Antibody 179NC75 Fab | |
| 7LM8 | 7LM8 | Crystal structure of SARS-CoV-2 spike protein receptor-binding domain in complex with two cross-neutralizing antibodies CV38-142 and COVA1-16 Fabs isolated from COVID-19 patients | |
| 7LM9 | 7LM9 | Crystal structure of SARS-CoV spike protein receptor-binding domain in complex with a cross-neutralizing antibody CV38-142 Fab isolated from COVID-19 patient | |
| 7LO6 | 7LO6 | Structure of CD4 mimetic BNM-III-170 in complex with BG505 SOSIP.664 HIV-1 Env trimer and 17b Fab | Envelope glycoprotein gp120, HIV-1 Envelope Glycoprotein BG505 SOSIP.664 gp41, 17b Fab Light Chain, 17b Fab Heavy Chain |
| 7LOK | 7LOK | Structure of CD4 mimetic M48U1 in complex with BG505 SOSIP.664 HIV-1 Env trimer and 17b Fab | Envelope Glycoprotein BG505 SOSIP.664 gp41, Envelope glycoprotein BG505 SOSIP.664 gp120, 17b Fab Light Chain, 17b Fab Heavy Chain, M48U1 |
| 7LOP | 7LOP | Crystal structure of SARS-CoV-2 receptor binding domain in complex with antibodies CV05-163 and CR3022 | |
| 7LPN | 7LPN | Cryo-EM structure of llama J3 VHH antibody in complex with HIV-1 Env BG505 DS-SOSIP.664 | |
| 7LQ7 | 7LQ7 | Crystal structure of SARS-CoV-2 receptor binding domain in complex with antibodies CV503 and COVA1-16 | |
| 7LQV | 7LQV | Cryo-EM structure of NTD-directed neutralizing antibody 4-8 Fab in complex with SARS-CoV-2 S2P spike | SARS-CoV-2 spike glycoprotein, neutralizing antibody 4-8 Fab |
| 7LQW | 7LQW | Cryo-EM structure of NTD-directed neutralizing antibody 2-17 Fab in complex with SARS-CoV-2 S2P spike | SARS-CoV-2 spike glycoprotein, neutralizing antibody 2-17 Fab |
| 7LRS | 7LRS | Cryo-EM structure of SARS-CoV-2 spike in complex with neutralizing antibody A23-58.1 that targets the receptor-binding domain | |
| 7LRT | 7LRT | Cryo-EM structure of SARS-CoV-2 spike in complex with neutralizing antibody A23-58.1 that targets the receptor-binding domain | |
| 7LS9 | 7LS9 | Cryo-EM structure of neutralizing antibody 1-57 in complex with prefusion SARS-CoV-2 spike glycoprotein | |
| 7LSS | 7LSS | Cryo-EM structure of the SARS-CoV-2 spike glycoprotein bound to Fab 2-7 | |
| 7LTB | 7LTB | Crystal Structure of Keratinicyclin B | |
| 7LU9 | 7LU9 | Cryo-EM structure of DH851.3 bound to HIV-1 CH505 Env | DH851.3 light chain, DH851.3 heavy chain, CH505 gp41, CH505 gp120 |
| 7LUA | 7LUA | Cryo-EM structure of DH898.1 Fab-dimer bound near the CD4 binding site of HIV-1 Env CH848 SOSIP trimer | CH848 SOSIP gp120, CH848 SOSIP gp41, DH898.1 light chain, DH898.1 heavy chain |
| 7LVW | 7LVW | Structure of RSV F in Complex with VHH Cl184 | |
| 7LWD | 7LWD | Cryo-EM structure of the wild-type human serotonin transporter complexed with vilazodone, imipramine and 15B8 Fab | |
| 7LX0 | 7LX0 | Quantitative assessment of chlorophyll types in cryo-EM maps of photosystem I acclimated to far-red light | |
| 7LX2 | 7LX2 | Cryo-EM structure of ConSOSL.UFO.664 (ConS) in complex with bNAb PGT122 | |
| 7LX3 | 7LX3 | Cryo-EM structure of EDC-crosslinked ConSOSL.UFO.664 (ConS-EDC) in complex with bNAb PGT122 | |
| 7LXM | 7LXM | Cryo-EM structure of ConM SOSIP.v7 (ConM) in complex with bNAb PGT122 | |
| 7LXN | 7LXN | Cryo-EM structure of EDC-crosslinked ConM SOSIP.v7 (ConM-EDC) in complex with bNAb PGT122 | |
| 7LXW | 7LXW | SARS-CoV-2 S/S2M11/S2X333 Local Refinement | S2X333 Fab Light Chain variable region, S2X333 Fab Heavy Chain variable region, Spike glycoprotein |
| 7LXX | 7LXX | SARS-CoV-2 S/S2M11/S2L28 Local Refinement | S2L28 Fab Heavy Chain variable region, S2L28 Fab Light Chain variable region, Spike glycoprotein |
| 7LXY | 7LXY | SARS-CoV-2 S/S2M11/S2X333 Global Refinement | Spike glycoprotein, S2M11 Fab Light Chain variable region, S2M11 Fab Heavy Chain variable region, S2X333 Fab Heavy Chain variable region, S2X333 Fab Light Chain variable region |
| 7LXZ | 7LXZ | SARS-CoV-2 S/S2M11/S2L28 Global Refinement | Spike glycoprotein, S2M11 Fab Light Chain variable region, S2M11 Fab Heavy Chain variable region, S2L28 Fab Heavy Chain variable region, S2L28 Fab Light Chain variable region |
| 7LY0 | 7LY0 | SARS-CoV-2 S/S2M11/S2M28 Local Refinement | Spike glycoprotein, S2M28 Fab Light Chain variable region, S2M28 Fab Heavy Chain variable region |
| 7LY2 | 7LY2 | SARS-CoV-2 S/S2M11/S2M28 Global Refinement | Spike glycoprotein, S2M11 Fab Light Chain variable region, S2M11 Fab Heavy Chain variable region, S2M28 Fab Heavy Chain variable region, S2M28 Fab Light Chain variable region |
| 7LY3 | 7LY3 | Crystal structure of SARS-CoV-2 S NTD bound to S2M28 Fab | |
| 7LY9 | 7LY9 | Cryo-EM structure of 2909 Fab in complex with 3BNC117 Fab and CAP256.wk34.c80 SOSIP.RnS2 N160K HIV-1 Env trimer | |
| 7M30 | 7M30 | Cryo-EM structure of the HCMV pentamer bound by antibodies 1-103, 1-32 and 2-25 | |
| 7M3G | 7M3G | Asymmetric Activation of the Calcium Sensing Receptor Homodimer | |
| 7M3I | 7M3I | Structure of SARS-CoV-2 spike protein receptor binding domain in complex with a neutralizing antibody, CV2-75 Fab | |
| 7M42 | 7M42 | Complex of SARS-CoV-2 receptor binding domain with the Fab fragments of neutralizing antibodies REGN10985 and REGN10989 | |
| 7M6D | 7M6D | Structure of the SARS-CoV-2 RBD in complex with neutralizing antibodies BG4-25 and CR3022 | |
| 7M6E | 7M6E | Structure of the SARS-CoV-2 S 6P trimer in complex with the human neutralizing antibody Fab fragment, BG10-19 | Spike glycoprotein, BG10-19 Fab Heavy Chain, BG10-19 Fab Light Chain |
| 7M6F | 7M6F | Structure of the SARS-CoV-2 S 6P trimer in complex with the human neutralizing antibody Fab fragment, BG1-22 | Spike glycoprotein, BG1-22 Fab Heavy Chain, BG1-22 Fab Light Chain |
| 7M6G | 7M6G | Structure of the SARS-CoV-2 S 6P trimer in complex with the human neutralizing antibody Fab fragment, BG7-15 | Spike glycoprotein, BG7-15 Fab Heavy Chain, BG7-15 Fab Light Chain |
| 7M6H | 7M6H | Structure of the SARS-CoV-2 S 2P trimer in complex with the human neutralizing antibody Fab fragment, BG7-20 | Spike glycoprotein, BG7-20 Fab Heavy Chain, BG7-20 Fab Light Chain |
| 7M6I | 7M6I | Structure of the SARS-CoV-2 S 2P trimer in complex with the human neutralizing antibody Fab fragment, BG1-24 | Spike glycoprotein, BG1-24 Fab Light Chain, BG1-24 Fab Heavy Chain |
| 7M71 | 7M71 | SARS-CoV-2 Spike:5A6 Fab complex I focused refinement | Spike glycoprotein, Fab 5A6 heavy chain, Fab 5A6 light chain |
